Andrea Grosso
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Semaphorin 3A promotes the long-term persistence of human SVF-derived microvascular networks in engineered grafts.
Journal: Frontiers in bioengineering and biotechnology
Published: March 05, 2024
VEGF dose controls the coupling of angiogenesis and osteogenesis in engineered bone.
Journal: NPJ Regenerative medicine
Published: September 28, 2022
Therapeutic arteriogenesis by factor-decorated fibrin matrices promotes wound healing in diabetic mice.
Journal: Journal of tissue engineering
Published: May 19, 2022
Robust coupling of angiogenesis and osteogenesis by VEGF-decorated matrices for bone regeneration.
Journal: Acta biomaterialia
Published: March 01, 2022
Robust Angiogenesis and Arteriogenesis in the Skin of Diabetic Mice by Transient Delivery of Engineered VEGF and PDGF-BB Proteins in Fibrin Hydrogels.
Journal: Frontiers in bioengineering and biotechnology
Published: March 30, 2021
Fibrin hydrogels promote scar formation and prevent therapeutic angiogenesis in the heart.
Journal: Journal of tissue engineering and regenerative medicine
Published: March 20, 2020
VEGF Over-Expression by Engineered BMSC Accelerates Functional Perfusion, Improving Tissue Density and In-Growth in Clinical-Size Osteogenic Grafts.
Journal: Frontiers in bioengineering and biotechnology
Published: February 02, 2020
It Takes Two to Tango: Coupling of Angiogenesis and Osteogenesis for Bone Regeneration.
Journal: Frontiers in bioengineering and biotechnology
Published: July 02, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026